KeyBanc analyst Matthew Gillmor reiterated an Overweight rating and $28.00 price target on Alignment Healthcare Inc (NASDAQ: ALHC).

The analyst commented: "What's the Deal with ALHC? Hitting the Debate Points, Still Seems Room to Run; ALHC's stock has been volatile post 1Q reporting and, even with Tuesday's rally, has underperformed in recent weeks. We believe most of the pressure/volatility has been driven by market rotation, as bellwethers UNH and HUM are viewed as more investable today vs. 2023-2025. Bears have also argued ALHC's 2026 guidance may be aggressive and point to 2Q MLR sequencing and recent CA stat filings. We think the bear points are overblown, especially in the context of moderating utilization. In our view, solid fundamentals and increasingly attractive valuation should sustain the recovery."

For an analyst ratings summary and ratings history on Alignment Healthcare Inc click here. For more ratings news on Alignment Healthcare Inc click here.

Shares of Alignment Healthcare Inc closed at $19.20 yesterday.